Mehlan Juliane, Schüttauf Frank, Salamon Johannes M, Kordes Uwe, Friedrich Reinhard E, Mautner Victor-Felix
Clinic of Ophthalmology, Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Clinic of Ophthalmology, Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Anticancer Res. 2019 Feb;39(2):827-831. doi: 10.21873/anticanres.13181.
This report describes the diagnosis and treatment of a 27-year-old patient with neurofibromatosis 1 (NF1) and late progression of a pre-existing optic pathway glioma (OPG) that caused significant reduction in vision. OPG is one of the diagnostic criteria for establishing the diagnosis of NF1. Most common findings of NF1 are café-au-lait spots, axillary and inguinal freckling of the skin, iris hamartoma (Lisch nodules), and tumors of the central nervous system and peripheral nerves. We successfully applied a modified International Society of Paediatric Oncology chemotherapy regimen for low-grade glioma in children with carboplatin dose adjustment according to the area under the plasma drug concentration-time curve calculation. During and after the chemotherapy, a clear improvement of the visual capacity was achieved. Age-adapted chemotherapy for symptomatic adult-onset OPG in patients with NF1 should be considered in individual cases.
本报告描述了一名27岁患有1型神经纤维瘤病(NF1)的患者的诊断和治疗情况,其既往存在的视神经通路胶质瘤(OPG)出现晚期进展,导致视力显著下降。OPG是确立NF1诊断的诊断标准之一。NF1最常见的表现为咖啡斑、腋窝和腹股沟皮肤雀斑、虹膜错构瘤(Lisch结节)以及中枢神经系统和周围神经肿瘤。我们成功应用了改良的国际儿科肿瘤学会儿童低级别胶质瘤化疗方案,并根据血浆药物浓度-时间曲线下面积计算调整卡铂剂量。化疗期间及化疗后,视力明显改善。对于NF1患者出现症状性成人期OPG,应根据个体情况考虑采用适合年龄的化疗。